SPL 2.11% 9.3¢ starpharma holdings limited

Remdesivir (Gilead) is currently a leading candidate for the treatment of COVID-19., page-5

  1. 587 Posts.
    lightbulb Created with Sketch. 79
    correct, that is the difference IMO. The potential for lasting protection and tolerability combined is the opportunity. Let’s see if they can do something with the opportunity.




 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.3¢
Change
-0.002(2.11%)
Mkt cap ! $38.35M
Open High Low Value Volume
9.5¢ 9.5¢ 9.3¢ $48.64K 512.2K

Buyers (Bids)

No. Vol. Price($)
3 153365 9.3¢
 

Sellers (Offers)

Price($) Vol. No.
9.8¢ 65000 1
View Market Depth
Last trade - 16.10pm 02/08/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.